Pharmaceutical success rests on a simple principle: prove the value of your treatments, or risk losing the chance to gain market access for your product. With overall healthcare costs climbing, payers have higher expectations for a medical treatment’s proof of value before paying for it.
Germany in particular has a set of very specific regulatory requirements that make market access different than in other countries. The legislation in the German healthcare environment especially contributes to a complex market access strategy. There are also different stakeholder groups with distinctive needs that must be met.
Read our brochure and learn how Quintiles can help you maximize opportunities in the German market.